AXSM

148.17

0.39% -0.58

시장 영업 전: 148.31 0.14 +0.09%

Axsome Therapeutics Inc (AXSM)

개요 뉴스 가격 이력 옵션 체인 Financials AXSM 왜 하락? 토론 예측

전일 마감가:

$148.75

열려 있는:

$148.67

하루 거래량:

554.08K

Relative Volume:

1.08

시가총액:

$7.47B

수익:

$338.46M

순이익/손실:

$-310.96M

주가수익비율:

-22.69

EPS:

-6.53

순현금흐름:

$-132.82M

1주 성능:

-0.70%

1개월 성능:

+5.19%

6개월 성능:

+39.45%

1년 성능:

+57.01%

1일 변동 폭

$144.13

$148.85

1주일 범위

$144.00

$151.51

52주 변동 폭

$75.56

$152.94

Axsome Therapeutics Inc Stock (AXSM) Company Profile

명칭

Axsome Therapeutics Inc

부문

Healthcare (1123)

산업

Biotechnology (627)

전화

(212) 332-3241

주소

ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK

직원

816

트위터

다음 수익 날짜

2025-02-18

최신 SEC 제출 서류

AXSM's Discussions on Twitter

AXSM을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AXSM Axsome Therapeutics Inc	148.17	7.50B	338.46M	-310.96M	-132.82M	-6.53
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-10-01	개시	B. Riley Securities	Buy
2025-09-03	재개	Wells Fargo	Overweight
2025-07-03	재개	Morgan Stanley	Overweight
2025-06-03	개시	Oppenheimer	Outperform
2025-04-07	개시	Jefferies	Buy
2025-02-11	개시	Deutsche Bank	Buy
2024-12-31	재확인	Mizuho	Outperform
2024-09-03	개시	Wells Fargo	Overweight
2024-08-06	업그레이드	BofA Securities	Neutral → Buy
2024-07-22	개시	Needham	Buy
2024-04-29	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-03-19	개시	Robert W. Baird	Outperform
2024-02-06	개시	UBS	Buy
2024-01-25	개시	RBC Capital Mkts	Outperform
2023-12-13	개시	Citigroup	Buy
2023-08-08	업그레이드	BofA Securities	Underperform → Neutral
2023-01-05	개시	Piper Sandler	Neutral
2022-11-01	개시	Loop Capital	Buy
2022-09-07	재개	Mizuho	Buy
2021-08-10	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-06-10	개시	Berenberg	Buy
2021-01-08	개시	Jefferies	Buy
2020-12-16	개시	Mizuho	Buy
2020-09-29	개시	BofA Securities	Underperform
2020-09-10	개시	Morgan Stanley	Overweight
2020-04-28	재확인	H.C. Wainwright	Buy
2020-04-14	개시	Cowen	Outperform
2019-12-30	재확인	H.C. Wainwright	Buy
2019-12-17	재확인	H.C. Wainwright	Buy
2019-12-16	재확인	Guggenheim	Buy
2019-10-16	개시	Guggenheim	Buy
2019-09-18	개시	William Blair	Outperform
2019-05-28	개시	SunTrust	Buy
2019-05-23	재확인	H.C. Wainwright	Buy
2019-04-08	개시	SVB Leerink	Outperform
2019-03-15	재확인	H.C. Wainwright	Buy
2016-10-03	재개	Brean Capital	Buy
2015-12-15	개시	Cantor Fitzgerald	Buy
2015-12-14	개시	Ladenburg Thalmann	Buy

모두보기

Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스

03:53 AM

Castleark Management LLC Buys 19,250 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

03:53 AM

Dec 13, 2025

TFG Asset Management GP Ltd Increases Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 13, 2025

RBC Capital Sticks to Its Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail

Dec 13, 2025